US Patent Issued to Deciphera Pharmaceuticals on Nov. 25 for "Heteroarylaminopyrimidine amide autophagy inhibitors and methods of use thereof" (Massachusetts, Kansas Inventors)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,479,833, issued on Nov. 25, was assigned to Deciphera Pharmaceuticals LLC (Waltham, Mass.).

"Heteroarylaminopyrimidine amide autophagy inhibitors and methods of use thereof" was invented by Daniel L. Flynn (Waltham, Mass.), Yu Mi Ahn (Waltham, Mass.), Timothy Caldwell (Lawrence, Kan.) and Lakshminarayana Vogeti (Waltham, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are compounds that are inhibitors of autophagy and their use in the treatment of disorders such as cancers."

The patent was filed on June 3, 2022, under Application No. 17/832,224.

*For further information, including images, charts and tables, please visit: http://p...